Asio Capital, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1803291 LEXINGTON, KY

Position in REGN

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$2,971,168

-$730,550 QoQ

Shares Held

4,765

-0.5% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.66%

of 13F equity value

Holder Rank

#460

of 1,322 holders

Holding Since

Mar 2021

20 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Asio Capital, LLC holds $2,971,168 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	REGN	Regeneron Pharmaceuticals, Inc. This page	4,765	$2,971,168

20 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,971,168	4,765	-0.5%	Shares	Sole	2026-07-17
2026-03-31	$3,701,718	4,791	+8.1%	Shares	Sole	2026-04-15
2025-12-31	$3,422,471	4,434	+11.0%	Shares	Sole	2026-01-21
2025-03-31	$2,533,748	3,995	+13.6%	Shares	Sole	2025-04-17
2024-12-31	$2,505,976	3,518	+25.9%	Shares	Sole	2025-01-21
2024-09-30	$2,937,164	2,794	+3.9%	Shares	Sole	2024-10-10
2024-06-30	$2,827,270	2,690	+5.7%	Shares	Sole	2024-07-17
2024-03-31	$2,449,537	2,545	+1.7%	Shares	Sole	2024-04-16
2023-12-31	$2,197,481	2,502	+1.4%	Shares	Sole	2024-01-11
2023-09-30	$2,031,065	2,468	+8.7%	Shares	Sole	2023-10-31
2023-06-30	$1,631,085	2,270	+1.2%	Shares	Sole	2023-08-03
2023-03-31	$1,843,005	2,243	+4.0%	Shares	Sole	2023-04-24
2022-12-31	$1,556,253	2,157	-50.5%	Shares	Sole	2023-01-27
2022-09-30	$3,004,162	4,361	+9.9%	Shares	Sole	2022-10-27
2022-06-30	$2,345,012	3,967	+2.4%	Shares	Sole	2022-08-04
2022-03-31	$2,706,377	3,875	+13.8%	Shares	Sole	2022-04-28
2021-12-31	$2,150,957	3,406	+12.4%	Shares	Sole	2022-02-14
2021-09-30	$1,833,695	3,030	+27.7%	Shares	Sole	2021-11-01
2021-06-30	$1,324,856	2,372	+34.0%	Shares	Sole	2021-07-30
2021-03-31	$837,457	1,770	—	Shares	Sole	2021-05-05
No filing history on record for this holder in this stock.